Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1995 1
1996 1
1997 1
1998 3
1999 2
2000 3
2001 1
2002 7
2003 9
2004 6
2005 4
2006 6
2007 3
2008 4
2009 3
2010 4
2011 4
2012 3
2013 13
2014 10
2015 6
2016 6
2017 2
2018 1
2019 7
2020 16
2021 9
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 12165619

128 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial.
O'Brien KL, Chandran A, Weatherholtz R, Jafri HS, Griffin MP, Bellamy T, Millar EV, Jensen KM, Harris BS, Reid R, Moulton LH, Losonsky GA, Karron RA, Santosham M; Respiratory Syncytial Virus (RSV) Prevention study group. O'Brien KL, et al. Lancet Infect Dis. 2015 Dec;15(12):1398-408. doi: 10.1016/S1473-3099(15)00247-9. Epub 2015 Nov 4. Lancet Infect Dis. 2015. PMID: 26511956 Clinical Trial.
Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children.
Iwane MK, Edwards KM, Szilagyi PG, Walker FJ, Griffin MR, Weinberg GA, Coulen C, Poehling KA, Shone LP, Balter S, Hall CB, Erdman DD, Wooten K, Schwartz B; New Vaccine Surveillance Network. Iwane MK, et al. Pediatrics. 2004 Jun;113(6):1758-64. doi: 10.1542/peds.113.6.1758. Pediatrics. 2004. PMID: 15173503
128 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page